PHILADELPHIA— Kiran Musunuru, MD, PhD, MPH, an associate professor of Cardiovascular Medicine and Genetics at the Perelman School of Medicine at the University of Pennsylvania, has been appointed editor in chief of Circulation: Cardiovascular Genetics. Musunuru will assume his new role on January 1, 2018, at which time the journal will become known as Circulation: Genomic and Precision Medicine.

“I am deeply honored to have been chosen for this position,” said Musunuru, whose research focuses on the genetics of cardiovascular and metabolic diseases. “I want to build on the outstanding work of my immediate predecessor, Dr. Ramachandran S. Vasan. The journal’s new name reflects the enormous progress being made in genomic and precision medicine at places such as Penn, and its potential to improve cardiovascular health.”

In his research, Musunuru works to understand how human genetic variation insulates some people from cardiovascular and metabolic disease and predisposes others, and to use that knowledge to generate new preventions and treatments. His tools include genome-wide association studies and sequencing to identify DNA variants and genes associated with cardiovascular disease. Musunuru also researches the use of stem cells for regenerative medicine, and the use of gene editing as a long-term treatment for disease.

“My vision is that the journal will be an indispensable resource for investigators and practitioners of cardiovascular genetics, ‘omics,’ and precision medicine,” said Musunuru. Examples of omics include genomics, proteomics, transcriptomics (the study of the transcriptome—the entire set of RNA transcripts produced by the genome) and metabolomics or biomarkers. He added “it will provide a forum for investigators to communicate excellent science, educate practitioners on both the basic tenets and the latest advances, and help define precision medicine as it takes shape over the next five years.”

The journal, one of 12 American Heart Association scientific journals, publishes research articles on human cardiovascular genetics, genomics, and systems biology. Under its new name, Circulation: Genomic and Precision Medicine will be a monthly, online publication. In addition to Musunuru’s appointment, Benjamin F. Voight, PhD, an associate professor of genetics at Penn, will be joining Circulation: Genomic and Precision Medicine as an associate editor, while Tilo Grosser, MD, a research associate professor of pharmacology at Penn, will continue his work at the journal as an associate editor.

Musunuru received his medical degree from Weill Cornell Medical College, his PhD degree from The Rockefeller University, and his MPH degree from Johns Hopkins Bloomberg School of Public Health. Before joining Penn Medicine in 2016, Musunuru trained in internal medicine at Brigham and Women’s Hospital and cardiovascular medicine at Johns Hopkins Hospital, followed by postdoctoral work at Massachusetts General Hospital and the Broad Institute of MIT and Harvard. 


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.

Share This Page: